The overall purpose of this randomized control trial (RCT) is to determine the clinical effect of a multilevel, RPM-enhanced intervention during and after completion of outpatient CAR-T therapy in 190 patients and their family caregivers (FCGs).
Documented informed consent of the participant and/or legally authorized representative Age and Language Criteria
Age ≥ 18 years old at the time of enrollment
Ability to read and understand English or Spanish for Questionnaires Nature of Illness and Treatment Related Criteria
Relapsed or refractory hematologic malignancy
An employee who is under the direct/indirect supervision of the PI/ a co-investigator/ the study manager 2. A direct study team member
City of Hope Medical Center
Lead sponsor
United States Department of Defense
Collaborator